The effect of clomiphene citrate and estradiol on body weight, vaginal cornification, and uterine weight after chronic treatment of ovarlectomized rats

1977 ◽  
Vol 33 (8) ◽  
pp. 1080-1082 ◽  
Author(s):  
W. L. Poteat
Author(s):  
Elvine P. Nguelefack-Mbuyo ◽  
Fernande P. Peyembouo ◽  
Christian K. Fofié ◽  
Télesphore B. Nguelefack

Abstract Objectives Dexamethasone is used experimentally to induce insulin resistance and type 2 diabetes. However, data concerning the dose, the duration of treatment, and the associated comorbidities are inconsistent. The aim of this study was to compare the effects of different doses of dexamethasone and the duration of treatment necessary for the development of a model of insulin resistance that mimics the clinical condition with the associated comorbidities. Methods Dexamethasone was administered intramuscularly to male Wistar rats, at doses of 500 and 1,000 µg/kg/day for the subchronic treatment (eight consecutive days) and at doses of 5, 25, 50, and 100 µg/kg/day in chronic treatment (28 consecutive days). Effects on body weight, metabolism, hemodynamics, renal function, and redox status were evaluated. Results Both treatments induced a progressive body weight loss that was drastic in subchronic treatment, improved glucose tolerance without affecting fasting glycemia. Doses of 1,000 and 100 µg/kg were associated with hypertriglyceridemia, hypertension, and increased heart rate, cardiac and renal hypertrophy. Increased creatinemia associated with reduced creatinuria were observed in sub-chronic treatment while increased proteinuria and reduced creatinuria were noticed in chronic treatment. 1,000 µg/kg dexamethasone caused an increase in hepatic, and renal malondialdehyde (MDA) and glutathione (GSH) coupled with a reduction in catalase activity. The dose of 100 µg/kg induced a rise in GSH and catalase activity but reduced MDA levels in the kidney. Conclusions Doses of 1,000 µg/kg for subchronic and 100 µg/kg for chronic treatment exhibited similar effects and are the best doses to respective time frames to induce the model.


2021 ◽  
Vol 15 (11) ◽  
pp. 2938-2941
Author(s):  
Fauzia Qureshi ◽  
Syeda Rizwana Jafri ◽  
Hafiza Sadia Ahmad ◽  
Uzma Waseem ◽  
Ursula Akif ◽  
...  

Background: Ovulation induction with clomiphene citrate in women with infertility has been practiced more than 40% years but in infertile patients this treatment plan proved to be ineffective with multiple complication. Body weight plays an important role modulating reproductive development and functioning. Aim: To observe the effects on body weight of female albino rat after use of clomiphene citrate and letrozole for consecutive 1-4 estrous cycles Method: Eighty four adult female Albino rats were equally divided into three groups for this research. Body weight of each rat was measured before and after the experiment. Vaginal smear cytology of each rat was performed to study different phases of estrous cycle. Control group A was given normal saline orally , In Experimental group B rats were given letrozole (Femara) at dose 5mg/kg orally and in Experimental group C rats were given clomiphene citrate at dose 100ug/kg orally. Results: Significant weight gain is observed in rats taking clomiphene citrate as compared to letrozole Conclusion : Comiphene citrate directly affects the body weight which indirectly reduces the ovulation induction and pregnancy rate. Letrozole is good alternate for ovulation induction and for CC resistant patients. Keywords: Estrous cycle, body weight, citrate and letrozole


1991 ◽  
Vol 3 (1) ◽  
pp. 25 ◽  
Author(s):  
JD Curlewis ◽  
AM Sibbald ◽  
JA Milne ◽  
AS McNeilly

The aim of this study was to determine whether suppression of the seasonal increase in prolactin concentrations by chronic treatment with the dopamine agonist bromocriptine would affect onset of anoestrus, voluntary food intake, body weight, and wool growth in a seasonal breed of sheep. Groups of eight Scottish Blackface ewes were injected i.m. each week with either the vehicle (Group A) or 2.0 mg (Group B), 6.0 mg (Group C), or 18.0 mg (Group D) of bromocriptine in a long-acting formulation, commencing on 18 January and terminating on 25 July (midwinter to midsummer in the northern hemisphere). Immediately before the bromocriptine injection, blood samples were taken for progesterone and prolactin determination. Voluntary food intakes were measured daily, and body weights were recorded every fortnight. Estimates of wool growth were made by weighing wool clipped from a measured area of skin once a month. Treatment had no effect on onset of anoestrus, voluntary food intake, body weight, or wool growth. Plasma prolactin concentrations increased significantly in all groups during the treatment period. From January to April, all doses of bromocriptine significantly reduced prolactin concentrations but later in the study (May and June) prolactin was significantly suppressed in Group D only, although even in this group prolactin concentrations increased between March and June. Pituitary prolactin content, measured at the end of the study in July, was also suppressed by bromocriptine. The gradual increase in prolactin concentrations in ewes receiving chronic bromocriptine was further investigated by treating a fifth group of ewes (Group E) with 18.0 mg of long-acting bromocriptine each week, commencing on 20 June.(ABSTRACT TRUNCATED AT 250 WORDS)


1985 ◽  
Vol 41 (1) ◽  
pp. 127-129 ◽  
Author(s):  
J. S. Walton

ABSTRACTGroups of five Yorkshire ♂ x Landrace ♀ gilts were either exposed (BE) or not exposed (NE) to a mature boar commencing at 140, 147, 154 or 161 days of age. Each group of BE gilts was slaughtered 10 days after initial boar exposure, for examination of the reproductive tract, with one of the four NE groups killed at a corresponding age.NE gilts remained prepubertal throughout. Boar exposure induced ovulation in one gilt at 140 days, two gilts at 147 days, two gilts at 154 days and one gilt at 161 days. Boar exposure also increased uterine weight (P < 0·001). There were no effects of age either on the number of gilts ovulating or on uterine weight. There was a significant positive effect of body weight on uterine weight which was greater in BE gilts than in NE gilts. These results suggest that body weight may be a determinant of the response to boar exposure by gilts between 140 and 170 days of age.


2014 ◽  
Vol 2014 ◽  
pp. 1-9 ◽  
Author(s):  
He Zhang ◽  
Ying Dong ◽  
Bin Qi ◽  
Li Liu ◽  
Guangxin Zhou ◽  
...  

Deer sinew (DS) has been used traditionally for various illnesses, and the major active constituent is collagen. In this study, we assessed the effects of collagen peptide from DS on bone loss in the ovariectomized rats. Wister female rats were randomly divided into six groups as follows: sham-operated (SHAM), ovariectomized control (OVX), OVX given 1.0 mg/kg/week nylestriol (OVX + N), OVX given 0.4 g/kg/day collagen peptide (OVX + H), OVX given 0.2 g/kg/day collagen peptide (OXV + M), and OVX given 0.1 g/kg/day collagen peptide (OXV + L), respectively. After 13 weeks of treatment, the rats were euthanized, and the effects of collagen peptide on body weight, uterine weight, bone mineral density (BMD), serum biochemical indicators, bone histomorphometry, and bone mechanics were observed. The data showed that BMD and concentration of serum hydroxyproline were significantly increased and the levels of serum calcium, phosphorus, and alkaline phosphatase were decreased. Besides, histomorphometric parameters and mechanical indicators were improved. However, collagen peptide of DS has no effect on estradiol level, body weight, and uterine weight. Therefore, these results suggest that the collagen peptide supplementation may also prevent and treat bone loss.


1977 ◽  
Vol 75 (3) ◽  
pp. 419-426 ◽  
Author(s):  
H. M. A. MEIJS-ROELOFS ◽  
P. KRAMER

The involvement of the adrenal gland in the release of gonadotrophins and the onset of puberty in female rats was studied. Two and four days after adrenalectomy (ADX) on either day 5 or 10 after birth, a significant decrease in the concentration of FSH was found; 4 days after ADX on either day 15 or 20, FSH concentrations had increased significantly compared with sham-operated and/or intact controls. However, in the rats adrenalectomized on day 15 or 20, the body weights were lower than in control rats. Relative uterine weights (mg/100 g body wt) in adrenalectomized rats never differed from those of control rats. A delay in the time at which vaginal opening and the first oestrus occurred was found in rats adrenalectomized at 20 or 25 days of age; however this delay was accompanied in these rats by a retardation in the gain in body weight. It is argued that the effects of ADX on both the release of gonadotrophins and the onset of puberty are primarily, and presumably exclusively, due to the effects on general bodily development (expressed in body weight). The lack of effect of ADX on uterine weight supports the hypothesis that 'oestrogen-like' products from the adrenal gland are not biologically active as oestrogens.


1968 ◽  
Vol 46 (1) ◽  
pp. 59-66 ◽  
Author(s):  
M. J. Fregly ◽  
I. W. Waters ◽  
J. A. Straw

Dietary administration of o,p′-DDD (2,2-bis(2-chlorophenyl, 4-chlorophenyl)-1,1-dichloroethane) at 1.0 and 3.0 g/kg food for 6 weeks increased the thyroid weight of male albino rats by 62 and 81% respectively. The rate of oxygen consumption (measured at 30 °C) and gain in body weight were unaffected by treatment. The rate of loss of 131I from the thyroid gland was significantly faster for both treated groups than for controls. These results suggest that the chronic administration of o,p′-DDD at the doses used resulted in a compensated hypothyroidism in rats. In another experiment, the thyroid weight of female hooded rats given m,p′-DDD (1.0 g/kg food) and p,p′-DDD (1.0 and 3.0 g/kg food) for 24 weeks also increased 112, 94, and 113% respectively above control weight. Ninety-six hours after the administration of thyroxine-131I, significantly greater fecal and less urinary excretion of radioactivity was observed for all treated groups than for the control group. The increase in thyroid weight of the treated rats may be associated with increased hepatic metabolism of thyroxine, but specific effects on the thyroid gland have not been excluded. Although isomers of DDD are reported to induce atrophy of the adrenal cortex and to reduce glucocorticoid secretion in dogs, no effect of the chronic administration of isomers of DDD on adrenal weight or production of either total Δ4-3 ketosteroids or corticosterone in vitro was observed in the case of rats. The rate of metabolism of desoxycorticosterone in vitro by rat liver slices was also unaffected by chronic treatment with o,p′-DDD.


2001 ◽  
Vol 20 (12) ◽  
pp. 619-623 ◽  
Author(s):  
R J Verma ◽  
D M Guna Sherlin

Oral administration of sodium fluoride (40 mg/kg body weight) from day 6 to 19 of gestation caused, as compared to control, significant reductions in body weight, feed consumption, absolute uterine weight and number of implantations. Significantly higher incidence of skeletal (wavy ribs, 14th rib, <6 sternal centre, dumbell-shaped second and fifth sternebrae, incomplete ossification of skull and thickening of tibia) and visceral (subcutaneous haemorrhage) abnormalities were also observed in NaF-treated dams than that of control. Oral administration of vitamin C (50 mg/kg body weight) and vitamin E (2 mg/0.2 ml olive oil/animal/day) from day 6 to 19 of gestation along with NaF significantly ameliorates NaF-induced reductions in body weight, feed consumption, absolute uterine weight (only with vitamin E treatment) and number of implantations. As compared with NaF-treated alone, the total percentage of skeletal and visceral abnormalities were significantly lowered in fluoride plus vitamin C-treated animals. Vitamin E was less effective. These findings suggest that vitamin C significantly reduced the severity and incidence of fluoride-induced embryotoxicity in rats.


2014 ◽  
Vol 59 (No. 11) ◽  
pp. 511-518 ◽  
Author(s):  
P. Tummaruk ◽  
S. Kesdangsakonwut

The objective of the present study was to determine the association between the uterine size and age, body weight, growth rate, and reproductive status in Landrace &times; Yorkshire crossbred gilts. Genital organs from 310 gilts (302.6 &plusmn; 2.9 days of age, 145.2 &plusmn; 1.2 kg body weight) were examined. The gilts were classified into two groups according to reproductive status: non-cyclic (n = 86) and cyclic (n = 224). The uterine weight in non-cyclic gilts was lower than that in cyclic ones (128 &plusmn; 8.1 and 694 &plusmn; 17.9 g, P &lt; 0.001). Likewise, the length of the uterus in non-cyclic gilts was shorter than that in cyclic gilts (123 &plusmn; 2.9 and 252 &plusmn; 4.6 cm, P &lt; 0.001). The weight of the uteri correlated with the body weight (r = 0.48, P &lt; 0.001) and growth rate (r = 0.33, P &lt; 0.001) of the gilts but not with their age (P &gt; 0.05). For every 10 kg increase in the body weight of the gilts, an increase of 67 g in uterine weight (P &lt; 0.001) and 21 cm in uterine length (P &lt; 0.001) was observed. &nbsp;


Sign in / Sign up

Export Citation Format

Share Document